| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | $5.7M | 1.1M | →First observed position No prior filed position | Q1 2026 | |
| 2 | Woodline Partners LP | $5.2M | 1.0M | —Held | Q1 2026 | |
| 3 | MARSHALL WACE, LLP | $5.0M | 966K | ▲+24% Added · +186K sh | Q1 2026 | |
| 4 | BAKER BROS. ADVISORS LP | $5.0M | 953K | —Held | Q1 2026 | |
| 5 | Affinity Asset Advisors, LLC | $4.5M | 868K | ▼−24% Reduced · −280K sh | Q1 2026 | |
| 6 | MILLENNIUM MANAGEMENT LLC | $4.5M | 862K | ▲+47% Added · +275K sh | Q1 2026 | |
| 7 | BlackRock, Inc. | $4.2M | 800K | ▼−1.7% Reduced · −14K sh | Q1 2026 | |
| 8 | HHLR ADVISORS, LTD. | $3.8M | 725K | —Held | Q1 2026 | |
| 9 | RENAISSANCE TECHNOLOGIES LLC | $3.3M | 625K | ▲+83% Added · +283K sh | Q1 2026 | |
| 10 | D. E. Shaw & Co., Inc. | $2.2M | 412K | ▼−15% Reduced · −74K sh | Q1 2026 | |
| 11 | RAYMOND JAMES FINANCIAL INC | $1.7M | 318K | ▲+11% Added · +31K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $1.6M | 310K | ▲+4.6% Added · +14K sh | Q1 2026 | |
| 13 | Hudson Bay Capital Management LP | $1.6M | 303K | ▼−0.4% Reduced · −1K sh | Q1 2026 | |
| 14 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.6M | 300K | —Held | Q1 2026 | |
| 15 | UBS Group AG | $1.5M | 294K | ▲+46% Added · +92K sh | Q1 2026 | |
| 16 | DIMENSIONAL FUND ADVISORS LP | $1.4M | 271K | ▲+99% Added · +135K sh | Q1 2026 | |
| 17 | Point72 Asset Management, L.P. | $980K | 188K | ▲+6.7% Added · +12K sh | Q1 2026 | |
| 18 | Qube Research & Technologies Ltd | $955K | 183K | ▲+64% Added · +71K sh | Q1 2026 | |
| 19 | GOLDMAN SACHS GROUP INC | $884K | 169K | ▲+34% Added · +43K sh | Q1 2026 | |
| 20 | VANGUARD FIDUCIARY TRUST CO | $850K | 163K | →First observed position No prior filed position | Q1 2026 | |
| 21 | STATE STREET CORP | $673K | 129K | ▲+9.7% Added · +11K sh | Q1 2026 | |
| 22 | 683 Capital Management, LLC | $660K | 126K | —Held | Q1 2026 | |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $651K | 125K | ▼−30% Reduced · −54K sh | Q1 2026 | |
| 24 | Squarepoint Ops LLC | $620K | 119K | ▲+40% Added · +34K sh | Q1 2026 | |
| 25 | RB Capital Management, LLC | $507K | 97K | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 24 funds | $8.6B |
| ALPHABET INC-CL AGOOGL | 24 funds | $5.7B |
| NVIDIA CORPNVDA | 23 funds | $13.4B |
| MICROSOFT CORPMSFT | 23 funds | $7.9B |
| META PLATFORMS INC-CLASS AMETA | 23 funds | $4.7B |
| BROADCOM INCAVGO | 22 funds | $5.1B |
| TAIWAN SEMICONDUCTOR-SP ADRTSM | 22 funds | $3.3B |
| ELI LILLY & COLLY | 22 funds | $2.1B |
| COCA-COLA CO/THEKO | 22 funds | $1.3B |
| ORACLE CORPORCL | 22 funds | $1.2B |
| UNITEDHEALTH GROUP INCUNH | 22 funds | $1.1B |
| COHERENT CORPCOHR | 22 funds | $523.3M |
Ranked by how many of SGMT's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Sell (S) | 3K | $14K |
| Feb 10, 2026 | Martins Eduardo Bruno | Chief Medical Officer | Sell (S) | 4K | $20K |
| Feb 10, 2026 | Chauche Thierry | Chief Financial Officer | Sell (S) | 1K | $7K |
| Feb 10, 2026 | Happel David | President & CEO, Director | Sell (S) | 12K | $65K |
| Nov 20, 2025 | Kemble George | Executive Chairman, Director | Sell (S) | 38K | $290K |
| Jul 21, 2025 | Rozek Elizabeth | General Counsel and CCO | Sell (S) | 11K | $98K |
| Jul 21, 2025 | Martins Eduardo Bruno | Chief Medical Officer | Sell (S) | 8K | $76K |
| Jul 21, 2025 | Happel David | President & CEO, Director | Sell (S) | 65K | $598K |
| Jul 23, 2024 | Kemble George | Executive Chairman, Director | Sell (S) | 24K | $75K |
| Jul 19, 2024 | Kemble George | Executive Chairman, Director | Sell (S) | 14K | $44K |
| Jul 19, 2024 | Rozek Elizabeth | General Counsel and CCO | Sell (S) | 11K | $34K |
| Jul 19, 2024 | Martins Eduardo Bruno | Chief Medical Officer | Sell (S) | 8K | $26K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/SGMT/capital-change-brief"
Use Arkolith's capital_change_brief for SGMT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for SGMT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.